CN103804470B - 一种特异性靶向肿瘤淋巴管的新型多肽tmvp1的获得及应用 - Google Patents
一种特异性靶向肿瘤淋巴管的新型多肽tmvp1的获得及应用 Download PDFInfo
- Publication number
- CN103804470B CN103804470B CN201410041476.XA CN201410041476A CN103804470B CN 103804470 B CN103804470 B CN 103804470B CN 201410041476 A CN201410041476 A CN 201410041476A CN 103804470 B CN103804470 B CN 103804470B
- Authority
- CN
- China
- Prior art keywords
- tumor
- lymphangiogenesis
- polypeptide
- tmvp1
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410041476.XA CN103804470B (zh) | 2014-01-22 | 2014-01-22 | 一种特异性靶向肿瘤淋巴管的新型多肽tmvp1的获得及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410041476.XA CN103804470B (zh) | 2014-01-22 | 2014-01-22 | 一种特异性靶向肿瘤淋巴管的新型多肽tmvp1的获得及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103804470A CN103804470A (zh) | 2014-05-21 |
CN103804470B true CN103804470B (zh) | 2016-08-17 |
Family
ID=50701899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410041476.XA Active CN103804470B (zh) | 2014-01-22 | 2014-01-22 | 一种特异性靶向肿瘤淋巴管的新型多肽tmvp1的获得及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103804470B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105983108A (zh) * | 2015-02-09 | 2016-10-05 | 珠海雅马生物工程有限公司 | 一种新型VEGFR-3受体显像剂99mTc-HYNIC/EDDA-TMVP1在肿瘤诊断中的应用 |
CN105126128B (zh) * | 2015-09-14 | 2018-07-20 | 武汉凯德维斯生物技术有限公司 | 一种肿瘤vegfr-3分子显像剂及其应用 |
CN114262692A (zh) * | 2021-11-30 | 2022-04-01 | 华中科技大学同济医学院附属同济医院 | 一种携带tmvp1和hsv-tk的溶瘤腺病毒重组体,其构建方法及应用 |
CN114317462A (zh) * | 2021-11-30 | 2022-04-12 | 武汉凯德维斯生物技术有限公司 | 一种携带TMVP1和tBid的溶瘤腺病毒重组体、其构建方法及应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5167155B2 (ja) * | 2006-03-09 | 2013-03-21 | ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム | ペプチド結合に基づく多数の細胞株のプロファイリングに関連した組成物および方法 |
CN102138889A (zh) * | 2011-03-25 | 2011-08-03 | 中国科学院深圳先进技术研究院 | 靶向载药超声微泡及其制备方法 |
-
2014
- 2014-01-22 CN CN201410041476.XA patent/CN103804470B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103804470A (zh) | 2014-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103804470B (zh) | 一种特异性靶向肿瘤淋巴管的新型多肽tmvp1的获得及应用 | |
CN103212071B (zh) | 干细胞融合癌发生模型 | |
Rothová et al. | Fate map of the dental mesenchyme: dynamic development of the dental papilla and follicle | |
AU2017245981A1 (en) | Polyethylene glycol-modified angiogenesis inhibitor HM-1 and application thereof | |
Connor et al. | Lymphatic endothelial lineage assemblage during corneal lymphangiogenesis | |
CN110547250B (zh) | 免疫健全的滑膜肉瘤异种移植小鼠模型的构建方法及应用 | |
CN105418769A (zh) | 一种具有抗肿瘤、抗炎症和治疗眼科疾病功能的融合蛋白及其制备方法和应用 | |
CN102552935B (zh) | 肝细胞核因子1α治疗慢性肝病的用途 | |
CN106552260A (zh) | 白介素37在调控血管生成疾病中的应用 | |
US20140121512A1 (en) | In vivo visualization of lymphatic tissue | |
CN106399252A (zh) | 一种口腔鳞癌细胞株、其制备方法及应用 | |
CN109503700A (zh) | 马来酰亚胺基团修饰的血管生成抑制剂hm-1及其应用 | |
CN107446023A (zh) | 一种可拮抗HuR蛋白RNA结合活性的多肽HIP‑13及其应用 | |
CN107129521A (zh) | 一种具有透过细胞膜或体组织屏障功能的肽及其应用 | |
Jun et al. | Experimental lens capsular bag model for posterior capsule opacification | |
CN110090228A (zh) | 人羊膜上皮细胞在自身免疫性疾病中的治疗用途 | |
CN113577066B (zh) | 芳基胍化合物或其药学上可接受的盐的用途 | |
Askenasy et al. | The topologic and chronologic patterns of hematopoietic cell seeding in host femoral bone marrow after transplantation | |
Cichon et al. | Imaging of neutrophils and neutrophil extracellular traps (NETs) with intravital (in vivo) microscopy | |
CN104922685A (zh) | 天然来源和/或自组装技术得到的生物膜、具有生物膜性的闭合结构或细胞区室作为医学高分子材料的应用 | |
CN107460170A (zh) | 人垂体腺瘤细胞系的建立及其应用 | |
CN106226531B (zh) | Angpt2在筛选或制备用于诊断或治疗血管瘤的药物中的应用 | |
CN110237087A (zh) | 核糖体s6激酶抑制剂sl0101在制备治疗心血管疾病药物中的应用 | |
Burgin et al. | Kidney Subcapsular Allograft Transplants as a Model to Test Virus-Derived Chemokine-Modulating Proteins as Therapeutics | |
CN100487754C (zh) | 一种用于构建人血管瘤鼠动物模型的细胞混合物的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180402 Address after: 430030 Department of gynecologic cancer laboratory in the 19 floor of Tongji Hospital outpatient building, Wuhan, Hubei Patentee after: Wuhan Kade Weiss Biotechnology Co., Ltd. Address before: 518057 high and new hi-tech incubator building in Shenzhen hi tech Zone, Guangdong Province, 2-201B Patentee before: Aonikesi Gene Technology Co., Ltd., Shenzhen City |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200110 Address after: 430030 Tongji Hospital, No. 1095 Jiefang Avenue, Hubei, Wuhan Patentee after: Tongji Hospital Attached to Tongji Medical College, Huazhong Science & Technolog Address before: 430030 Department of gynecologic cancer laboratory in the 19 floor of Tongji Hospital outpatient building, Wuhan, Hubei Patentee before: Wuhan Kade Weiss Biotechnology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201112 Address after: 430075 factory building 1, floor 1, building 15, enterprise accelerator phase 3.1, Wuhan Optical Valley International Biomedical Park, no.388, Gaoxin 2nd Road, Donghu New Technology Development Zone, Wuhan, Hubei Province Patentee after: WUHAN KAIDEWEISI BIOTECHNOLOGY Co.,Ltd. Address before: 430030 Tongji Hospital, No. 1095 Jiefang Avenue, Hubei, Wuhan Patentee before: Huazhong University of Science Tongji Hospital, Tongji Medical College |